I don’t think they do much work on the new indications but put more lipstick on the pig for the possible takeover .
Little T, that’s an unfortunate comment, in my opinion.
Putting lipstick on a pig implies the tarting up of a product with cosmetic changes in a futile effort to disguise its fundamental failings. So I’m lost as to why you would belittle NNZ-2591 with this description, in contrast to Jon Pilcher’s description of NNZ-2591 as “the jewel in the crown”.
As for the company not doing much work on new indications, my thoughts are that there would be a great deal of research and analysis that would go into the selection of new indications. Then there’s preclinical testing and IP protection to be considered as well. Again, I’m not sure why you would belittle the hard work of the company in this way.
NEU Price at posting:
$11.03 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)